GrandOmics

OverviewSuggest Edit

GrandOmics (希望组) is a company developing genomics solutions for disease research and diagnosis. It provides sequencing platforms in the field of genetic diseases, cancer, and the human microbiome, including whole-genome sequencing, full-length transcriptome sequencing, whole-genome methylation sequencing, etc.
TypePrivate
Founded2014
HQCN
Websitegrandomics.com

Locations

GrandOmics is headquartered in
China

Location Map

Latest Updates

Cybersecurity ratingBMore

Key People/Management at GrandOmics

Depeng Wang

Depeng Wang

CEO
Xiangwen Hao

Xiangwen Hao

CEO
Show more

GrandOmics Office Locations

GrandOmics has an office in
Show all (1)

GrandOmics Financials and Metrics

Summary Metrics

Founding Date

2014

GrandOmics total Funding

$29 m

GrandOmics latest funding size

$15 m

Time since last funding

3 years ago

GrandOmics investors

GrandOmics's latest funding round in July 2018 was reported to be $15 m. In total, GrandOmics has raised $29 m
Show all financial metrics

GrandOmics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

GrandOmics Online and Social Media Presence

Embed Graph

GrandOmics Frequently Asked Questions

  • When was GrandOmics founded?

    GrandOmics was founded in 2014.

  • Who are GrandOmics key executives?

    GrandOmics's key executives are Depeng Wang and Xiangwen Hao.

  • Who are GrandOmics competitors?

    Competitors of GrandOmics include GeneDx, Igenomix and Shanghai Fudan-Zhangjiang Bio-Pharmaceutical.

  • Where are GrandOmics offices?

    GrandOmics has an office in.

  • How many offices does GrandOmics have?

    GrandOmics has 1 office.